[Therapy of malignant supratentorial neuroepithelial tumors and the possibility of the pretherapeutic sensitivity testing of cytostatics].
Today, the treatment of malignant gliomas is carried out surgically, radiotherapeutically or chemotherapeutically. In the field of radiotherapy, promising trials with radiosensitizers have been carried out which might increase the effectiveness of the irradiation of gliomas. Chemotherapy without a combination with the other above mentioned therapies is not promising. Test models for the pretherapeutic prediction of the individual cytostatic activity are available both in the form of experiments and short-term or long-term in-vitro tests without any of the test models having sufficiently reflected the in-vivo conditions up to now.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000473:pathology / Q000601:surgery*; D003131:Combined Modality Therapy; D005910:Glioma / Q000473:pathology / Q000601:surgery*; D006801:Humans; D009367:Neoplasm Staging; D011379:Prognosis; D011879:Radiotherapy Dosage
D000970:Antineoplastic Agents
Zur Therapie maligner supratentorieller neuroepithelialer Tumoren und der Möglichkeit der prätherapeutischen Sensibilitätstestung von Zytostatika.